Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder

Recruiting now · Phase 2

Conditions studied: Stimulant Use Disorder

In brief

The purpose of this study is to determine the effects of suvorexant (SUVO), on sleep, stress, and drug craving during early abstinence from stimulants and to determine the effects of treatment (SUVO vs. treatment as usual (TAU)) on post-treatment (Days 13-30) residential program length of stay (LOS) and completion rate.

Key facts

Study ID
NCT06444256
Run by
The University of Texas Health Science Center, Houston
People needed
20
Starts
2024-07-25
Expected to finish
2027-01-30
Last updated by the study team
2025-09-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.